The Journal of
Clinical Psychiatry

Volume 66 • 2005 • 11

Original Research

The Epidemiology of Social Anxiety Disorder in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

J Clin Psychiatry 2005;66(11):1351-1361

Bridget F. Grant, PhD ; Deborah S. Hasin, PhD ; Carlos Blanco, MD, PhD ; Frederick S. Stinson, PhD ; S. Patricia Chou, PhD ; Risë B. Goldstein, PhD, MPH ; Deborah A. Dawson, PhD ; Sharon Smith, PhD ; Tulshi D. Saha, PhD ; Boji Huang, MD, PhD

Original Research

Efficacy of Aripiprazole Against Hostility in Schizophrenia and Schizoaffective Disorder: Data From 5 Double-Blind Studies

J Clin Psychiatry 2005;66(11):1362-1366

Jan Volavka, MD ; Pal Czobor, PhD ; Leslie Citrome, MD, MPH ; Robert D. McQuade, PhD ; William H. Carson, MD ; Dusan Kostic, PhD ; Sterling Hardy, MS ; Ronald Marcus, MD

Original Research

Clinical Characteristics and Psychiatric Comorbidity in Males With Exhibitionism

J Clin Psychiatry 2005;66(11):1367-1371

Jon E. Grant, JD, MD

Original Research

Treatment of the Polydipsia-Hyponatremia Syndrome With Urea

J Clin Psychiatry 2005;66(11):1372-1375

Anne Verhoeven, MD ; Wim Musch, MD ; Guy Decaux, MD, PhD

Original Research

Typical and Atypical Antipsychotics in Bipolar Depression

J Clin Psychiatry 2005;66(11):1376-1385

Keming Gao, MD, PhD ; Prashant Gajwani, MD ; Omar Elhaj, MD ; Joseph R. Calabrese, MD

Original Research

QTc Interval Measurement and Metabolic Parameters in Psychiatric Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary Study

J Clin Psychiatry 2005;66(11):1386-1391

Paul Mackin, MB, BS, PhD, MRCPsych ; Allan H. Young, MB, ChB, PhD, FRCPsych

Original Research

Sequential Treatment of Mood and Anxiety Disorders

J Clin Psychiatry 2005;66(11):1392-1400

Giovanni A. Fava, MD ; Chiara Ruini, PhD ; Chiara Rafanelli, MD, PhD

Original Research

The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study

J Clin Psychiatry 2005;66(11):1401-1408

Mark H. Pollack, MD ; Peter P. Roy-Byrne, MD ; Michael Van Ameringen, MD, FRCPC ; Heather Snyder, PhD ; Charles Brown, MD ; John Ondrasik, PhD ; Karl Rickels, MD

Original Research

Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine

J Clin Psychiatry 2005;66(11):1409-1414

J. Craig Nelson, MD ; Laura Portera, MS ; Andrew C. Leon, PhD

Original Research

Cognitive Therapy and Exposure in Vivo Alone and in Combination With Fluvoxamine in Obsessive-Compulsive Disorder: A 5-Year Follow-Up

J Clin Psychiatry 2005;66(11):1415-1422

Patricia van Oppen, PhD ; Anton J. L. M. van Balkom, MD, PhD ; Else de Haan, PhD ; Richard van Dyck, MD, PhD

Original Research

Variables Associated With Alcohol, Drug, and Daily Smoking Cessation in Patients With Severe Mental Illnesses

J Clin Psychiatry 2005;66(11):1447-1455

Jose de Leon, MD ; Margaret T. Susce, RN, MLT ; Francisco J. Diaz, PhD ; Diego M. Rendon, BS ; Diana M. Velásquez, BS

Original Research

Naturalistic, Retrospective Comparison Between Second-Generation Antipsychotics and Depot Neuroleptics in Patients Affected by Schizophrenia

J Clin Psychiatry 2005;66(11):1423-1431

Livio Marchiaro, MD ; Paola Rocca, MD ; Ferdinando LeNoci, MD ; Pierpaolo Longo, MD ; Cristiana Montemagni, MD ; Cristiana Rigazzi, MD ; Filippo Bogetto, MD

Original Research

Misdiagnosed Patients With Bipolar Disorder: Comorbidities, Treatment Patterns, and Direct Treatment Costs

J Clin Psychiatry 2005;66(11):1432-1440

Louis S. Matza, PhD ; Krithika S. Rajagopalan, PhD, MS ; Christine L. Thompson, BS ; Gregory de Lissovoy, PhD

Original Research

Safety and Efficacy of Escitalopram in the Long-Term Treatment of Generalized Anxiety Disorder

J Clin Psychiatry 2005;66(11):1441-1446

Jonathan R. T. Davidson, MD ; Anjana Bose, PhD ; Qin Wang, PhD

Original Research

Suicidal Ideation and Attempts in Bipolar I and II Disorders

J Clin Psychiatry 2005;66(11):1456-1462

Hanna Valtonen, MD ; Kirsi Suominen, MD, PhD ; Outi Mantere, MD ; Sami LeppÃ¤mÃ¤ki, MD ; Petri Arvilommi, MD ; Erkki T. IsometsÃ¤, MD, PhD

Original Research

Undiagnosed Hyperglycemia in Patients Treated With Atypical Antipsychotics

J Clin Psychiatry 2005;66(11):1463-1467

Michael J. Sernyak, MD ; Barbara Gulanski, MD ; Robert Rosen heck, MD

Original Research

Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder

J Clin Psychiatry 2005;66(11):1468-1476

Scott W. Andersen, MS ; David B. Clemow, PhD ; Sara A. Corya, MD

Original Research

Untangling Depression and Anxiety: Clinical Challenges

J Clin Psychiatry 2005;66(11):1447-1487

Martin B. Keller, MD ; John H. Krystal, MD ; René Hen, PhD ; Alexander Neumeister, MD ; Naomi M. Simon, MD, MSc

Commentary

Hurricane Katrina: A Physician's Whirlwind Course in Disaster Psychiatry

J Clin Psychiatry 2005;66(11):1349-1350

Shane Stephen Spicer, MD

ASCP Corner

Sexual Function and Dysfunction During Treatment With Psychotropic Medications

J Clin Psychiatry 2005;66(11):1488-1489

Richard Balon, MD

Letter to the Editor

Clozapine-Induced Pericarditis, Pericardial Tamponade, Polyserositis, and Rash

J Clin Psychiatry 2005;66(11):1491-1492

Moeen A. Bhatti, MD ; Janet Zander, MD ; Elizabeth Reeve, MD

Letter to the Editor

Applying Parsimony to "An African Patient With Ziprasidone Intolerance."

J Clin Psychiatry 2005;66(11):1491-1491

Jeffrey L. Anders, MD

Letter to the Editor

Reply to Applying Parsimony to "An African Patient With Ziprasidone Intolerance"

J Clin Psychiatry 2005;66(11):1491-1492

Jakob Hein, MD

Letter to the Editor

Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder

J Clin Psychiatry 2005;66(11):1492-1493

Christopher Pittenger, MD, PhD ; John H. Krystal, MD ; Vladimir Coric, MD

Letter to the Editor

Orally Disintegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia

J Clin Psychiatry 2005;66(11):1493-1494

Frank L. Tornatore, PharmD

Letter to the Editor

Reply to "Orally Distegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia"

J Clin Psychiatry 2005;66(11):1494-1494

John M. Kane, MD

Letter to the Editor

Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety

J Clin Psychiatry 2005;66(11):1494-1495

Jennifer McClendon, MSW

Letter to the Editor

Reply to "Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety

J Clin Psychiatry 2005;66(11):1495

Shaila Misri, MD ; Pratibha Reebye, MD ; Maria Corral, MD ; Lisa Milis, BA

Book Review

Brain Stimulation in Psychiatric Treatment

J Clin Psychiatry 2005;66(11):1496-1496

Kevin J. Black, MD

Book Review

Introduction to Psychoneuroimmunology

J Clin Psychiatry 2005;66(11):1496-1496

Ronald M. Salomon

Volume 66 • 2005 • 11

Original Research

The Epidemiology of Social Anxiety Disorder in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Efficacy of Aripiprazole Against Hostility in Schizophrenia and Schizoaffective Disorder: Data From 5 Double-Blind Studies

Clinical Characteristics and Psychiatric Comorbidity in Males With Exhibitionism

Treatment of the Polydipsia-Hyponatremia Syndrome With Urea

Typical and Atypical Antipsychotics in Bipolar Depression

QTc Interval Measurement and Metabolic Parameters in Psychiatric Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary Study

Sequential Treatment of Mood and Anxiety Disorders

The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study

Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine

Cognitive Therapy and Exposure in Vivo Alone and in Combination With Fluvoxamine in Obsessive-Compulsive Disorder: A 5-Year Follow-Up

Variables Associated With Alcohol, Drug, and Daily Smoking Cessation in Patients With Severe Mental Illnesses

Naturalistic, Retrospective Comparison Between Second-Generation Antipsychotics and Depot Neuroleptics in Patients Affected by Schizophrenia

Misdiagnosed Patients With Bipolar Disorder: Comorbidities, Treatment Patterns, and Direct Treatment Costs

Safety and Efficacy of Escitalopram in the Long-Term Treatment of Generalized Anxiety Disorder

Suicidal Ideation and Attempts in Bipolar I and II Disorders

Undiagnosed Hyperglycemia in Patients Treated With Atypical Antipsychotics

Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder

Untangling Depression and Anxiety: Clinical Challenges

Commentary

Hurricane Katrina: A Physician's Whirlwind Course in Disaster Psychiatry

ASCP Corner

Sexual Function and Dysfunction During Treatment With Psychotropic Medications

Letter to the Editor

Clozapine-Induced Pericarditis, Pericardial Tamponade, Polyserositis, and Rash

Applying Parsimony to "An African Patient With Ziprasidone Intolerance."

Reply to Applying Parsimony to "An African Patient With Ziprasidone Intolerance"

Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder

Orally Disintegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia

Reply to "Orally Distegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia"

Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety

Reply to "Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety

Book Review

Brain Stimulation in Psychiatric Treatment

Introduction to Psychoneuroimmunology

ELSEWHERE:

FOLLOW US:

Volume 66 • 2005 • 11

Original Research

The Epidemiology of Social Anxiety Disorder in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Efficacy of Aripiprazole Against Hostility in Schizophrenia and Schizoaffective Disorder: Data From 5 Double-Blind Studies

Clinical Characteristics and Psychiatric Comorbidity in Males With Exhibitionism

Treatment of the Polydipsia-Hyponatremia Syndrome With Urea

Typical and Atypical Antipsychotics in Bipolar Depression

QTc Interval Measurement and Metabolic Parameters in Psychiatric Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary Study

Sequential Treatment of Mood and Anxiety Disorders

The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study

Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine

Cognitive Therapy and Exposure in Vivo Alone and in Combination With Fluvoxamine in Obsessive-Compulsive Disorder: A 5-Year Follow-Up

Variables Associated With Alcohol, Drug, and Daily Smoking Cessation in Patients With Severe Mental Illnesses

Naturalistic, Retrospective Comparison Between Second-Generation Antipsychotics and Depot Neuroleptics in Patients Affected by Schizophrenia

Misdiagnosed Patients With Bipolar Disorder: Comorbidities, Treatment Patterns, and Direct Treatment Costs

Safety and Efficacy of Escitalopram in the Long-Term Treatment of Generalized Anxiety Disorder

Suicidal Ideation and Attempts in Bipolar I and II Disorders

Undiagnosed Hyperglycemia in Patients Treated With Atypical Antipsychotics

Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder

Untangling Depression and Anxiety: Clinical Challenges

Commentary

Hurricane Katrina: A Physician's Whirlwind Course in Disaster Psychiatry

ASCP Corner

Sexual Function and Dysfunction During Treatment With Psychotropic Medications

Letter to the Editor

Clozapine-Induced Pericarditis, Pericardial Tamponade, Polyserositis, and Rash

Applying Parsimony to "An African Patient With Ziprasidone Intolerance."

Reply to Applying Parsimony to "An African Patient With Ziprasidone Intolerance"

Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder

Orally Disintegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia

Reply to "Orally Distegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia"

Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety

Reply to "Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety

Book Review

Brain Stimulation in Psychiatric Treatment

Introduction to Psychoneuroimmunology

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles